Abstract
Introduction 49 50
Endometrial and ovarian cancers are the commonest cancers in post-menopausal 51 women worldwide. In the UK alone, 9,300 women develop endometrial cancer, of whom 2,100 already metastasized within the abdomen, resulting in late-stage disease and poor prognoses 5 .
59
An accurate and early diagnosis of both diseases, and especially ovarian cancer, is of major 60 need as it would permit an early intervention and potentially early-stage diagnosis and 61 consequently improved prognosis.
62
The gold standard for diagnosis of endometrial cancer is biopsy performed either in an 63 outpatient or inpatient setting after a patient presents with symptomatic bleeding. For ovarian 64 cancer diagnosis in patients with symptoms, women initially undergo a pelvic examination,
65
followed by measurement of serum cancer antigen (CA-125); if symptoms persist in the 66 absence of raised CA-125 levels, an abdominal and transvaginal ultrasound follow 5 . In 67 asymptomatic women for ovarian cancer screening, a combination of these biomarkers is used.
68
In the future, with the escalating incidence of endometrial cancer secondary to obesity, there 69 might be a role for screening for disease. All of the above-mentioned diagnostic approaches 70 have drawbacks, either being invasive (e.g., biopsy) or expensive (e.g., ultrasound PCA-SVM were optimized using cross-validation venetian blinds in a "leave one patient out" 150 fashion (10 splits with 1 sample per split). GA-LDA was optimized using an external validation 151 data set having half of the samples of the test set. The algorithm was applied three times, using 152 100 generations with 200 chromosomes, and the best model was selected. Crossover and 153 mutation probabilities were set to 60% and 10%, respectively.
154
In order to study the differences at specific wavenumbers, we implemented a simple 155 approach, namely difference-between-means (D-B-M) spectra, which subtracts the mean 156 spectra from a reference class (i.e., healthy controls). A peak-detecting algorithm was then used 157 to denote six of the most differentiating peaks. All data (raw and pre-processed spectra) All spectra were pre-processed before comparison of the cancer patients with the 186 healthy controls. Supplementary Fig. 1A shows the average pre-processed spectra for each Fig. 1B) . Fig.   192 1 shows the differences in the absorbance of the above-mentioned peaks; a general increase 193 was denoted in the endometrial cancer patients with the exception of the peaks at 1593 cm (Fig. 5B ). GA-LDA (C).
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